ICOA conferences in june 2022 : thursday 02/06 at 10:30 IRD amphitheatre Prof. C. Turner (Lund University, Sweden) « Exploring sub- and supercritical fluids as green solvents in analytical-scale extraction and analysis » thursday 16/06 at 11:00 seminar room of ICOA Prof. I. Namboothiri (IIT Bombay, India) « Synthesis of Novel Carbocyclic and Heterocyclic Scaffolds from α-Functionalized Nitroalkenes » Contact: Marie-Aude HIEBEL and Vincent ROY ICOA – UMR 7311 / Université d’Orléans rue de Chartres B.P. 6759 – F-45067 Orléans Cedex 2, France mailto: vincent.roy@univ-orleans.fr / marie-aude.hiebel@univ-orleans.fr tel: + 33 (0)2 38 49 45 72 / + 33 (0)2 38 49 45...
Lire plus »
Thesis topic ARED-LCC CD35-ve Subject: Original chelates modified by peptides for hepatic tumour targeting: synthesis, characterisation, radiolabelling and in vitro/in vivo evaluation Application deadline: may 30, 2022 Starting date: october 2022 Funding: ARED/Ligue contre le Cancer (36 months) Contacts: Sandrine Cammas-Marion : sandrine.marion.1@ensc-rennes.fr Mickaël Bourgeois : mickael.bourgeois@univ-nantes.fr Nicolas Lepareur : n.lepareur@rennes.unicancer.fr...
Lire plus »
A gathering of world-renowned experts in radiopharmaceutical sciences in Nantes From 29th May to 2nd June 2022, around 400 researchers from the world over will gather at the Cité des Congrès in Nantes for the 24th edition of the “International Symposium on Radiopharmaceutical Sciences” (iSRS 2022). An occasion for radiochemists, radiopharmacists and clinicians to review the latest advances in their respective speciality fields and to share research on the development of nuclear medicine, with a particular focus on personalised strategies in the fields of oncology and neurology. Several members of the Nantes scientific community will be attending the conference. Organised jointly by members of the scientific community at the universities of Nantes, Rennes, Caen, Tours, the Centre de Lutte Contre le Cancer in Rennes and the CEA Paris-Saclay (Orsay), the Nantes edition of the International Symposium of the Society of Radiopharmaceutical Sciences (SRS) aims to present a comprehensive overview of current research in all aspects of radiopharmaceutical sciences: from drug synthesis based on the use of radiation for medical purposes to clinical studies on new targeted tracers, including pre-clinical studies, in vivo biodistribution and imaging. Gathering from around the globe, participants in the iSRS 2022 conference in Nantes will discuss the latest topics concerning the development of radiopharmaceuticals, including: neurology, radiometals, the theranostic approach, nanomedicine, the chemistry of Fluorine-18 and Carbon-11, the use of imaging in oncology, targetry, automation and microfluidics, therapies in oncology or bioconjugation technologies. Focus on young researchers! The Nantes edition of the iSRS conference is developing a wide range of initiatives targeting students and young researchers engaged in courses and career development in the area of radiopharmaceutical sciences. According to the local organising committee, “A pre-workshop for young researchers, led by young researchers assisted by more experienced scientists, will be held the day before the conference opens.” These young researchers will also be able to participate in the Radiopharmaceutical Sciences Olympiads, a video competition aiming to promote radiopharmaceutical sciences and technologies to the general public. The organisers add, “Participating in this competition will allow young researchers to enter into contact with globally-established radiopharmaceutical organisations.” In addition to regular scientific reports in the form of oral or poster presentations, PhD students will have an opportunity to present their research in a brief speech similar to the competition model “My doctoral thesis in 180 seconds”. Lastly, the SRS will provide grants to young researchers from the Americas and Asia to help them cover the cost of their subscription and fund their visit to Nantes. The Nantes scientific ecosystem is strongly involved in the development of nuclear medicine This ecosystem includes research laboratories, specialised hospital departments, cyclotron, training schemes and establishments, and innovation-driving SME. In the space of a few years, Nantes has created a robust network of multidisciplinary skills and expertise dedicated to the development of nuclear medicine. Academic stakeholders involved in nuclear medicine research and...
Lire plus »
Dear colleague, The radiobiology unit of SCK CEN, Mol, Belgium is looking for a research project leader to contribute to the research on effects of radiation therapy on human health with a particular focus on the central nervous and cardiovascular systems. This project leader will participate in radiation induced health research development of strategies to identify and implement (novel) sensitive technologies for assessing disease initiation and long-term health effects as well as (individual) responses to radiation therapy. Please find hereunder the full job description for more information. https://www.sckcen.be/en/careers/vacancies/research-project-leader-radiation-induced-health-effects Deadline to apply is 4th of May. Prof Sarah Baatout Head of Radiobiology Unit Belgian Nuclear Research Centre +32 14 33 27 29...
Lire plus »
Dear Colleague: Our community has been through a lot over the past two years, and all of us are looking forward to resuming our normal habits and routines. We are excited to see everyone in person at iSRS 2022 in the historical city center of Nantes, France. The iSRS symposium series has a long and treasured history of providing valued interaction between colleagues throughout the world. Program development is being guided by a team of internationally respected leaders within the field. This conference aims to address original research in all aspects of radiopharmaceutical science; synthesis, in vitro and ex vivo studies, in vivo biodistribution or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers. The iSRS 2022 Program Committee and I are pleased to announce that we received over 400 complete abstract submissions. We appreciate all who submitted and regard this as a good number, given current COVID-19 realities. COVID-19 and iSRS 2022 (the latest information) French COVID-19 restrictions are being progressively lifted, and the government is talking about the suppression of the vaccination passes by mid-March, if the decrease in the number of cases continues. We are assuming that by May all restrictions will be lifted. So far, all European citizens can travel within the EU without any restriction. But people must ensure before traveling that they comply with the rules imposed by airline and train companies. From the French government and updated frequently: https://www.diplomatie.gouv.fr/en/coming-to-france/coming-to-france-your-covid-19-questions-answered/ We are very much looking forward to a successful return to an in-person iSRS symposium! REGISTRATION (early registration ends march 31): here Stay tuned for iSRS 2022 updates. Sincerely, Sandrine Huclier iSRS 2022 Program Chair...
Lire plus »
